Effect of Renal Impairment on the Pharmacokinetics of NN9535
Status:
Completed
Trial end date:
2010-07-26
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this clinical trial
is to investigate how different degrees of renal impairment (mild, moderate, severe and
end-stage renal disease) affect the pharmacokinetics of NN9535.